Pediatric Solid Tumors in Resource-Constrained Settings: A Review of Available Evidence on Management, Outcomes, and Barriers to Care
- PMID: 30360527
- PMCID: PMC6262277
- DOI: 10.3390/children5110143
Pediatric Solid Tumors in Resource-Constrained Settings: A Review of Available Evidence on Management, Outcomes, and Barriers to Care
Abstract
International disparities in outcomes from pediatric solid tumors remain striking. Herein, we review the current literature regarding management, outcomes, and barriers to care for pediatric solid tumors in low- and middle-income countries (LMICs). In sub-Saharan Africa, Wilms Tumor represents the most commonly encountered solid tumor of childhood and has been the primary target of recent efforts to improve outcomes in low-resource settings. Aggressive and treatment-resistant tumor biology may play a role in poor outcomes within certain populations, but socioeconomic barriers remain the principal drivers of preventable mortality. Management protocols that include measures to address socioeconomic barriers have demonstrated early success in reducing abandonment of therapy. Further work is required to improve infrastructure and general pediatric care to address disparities.
Keywords: Wilms Tumor; barriers to care; disparities; low and middle-income countries (LMICs); pediatric solid tumor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Tournade M.F., Com-Nougue C., de Kraker J., Ludwig R., Rey A., Burgers J.M., Sandstedt B., Godzinski J., Carli M., Potter R., et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms’ tumor in children older than 6 months: Results of the Ninth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study. J. Clin. Oncol. 2001;19:488–500. doi: 10.1200/JCO.2001.19.2.488. - DOI - PubMed
-
- de Kraker J., Graf N., van Tinteren H., Pein F., Sandstedt B., Godzinski J., Tournade M.F. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms’ tumour (SIOP 93-01 trial): A randomised controlled trial. Lancet. 2004;364:1229–1235. doi: 10.1016/S0140-6736(04)17139-0. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
